In this regard, the overexpression of carnitine palmitoyl transferase-1A (CPT-1A), the rate-limiting enzyme of FAO, has been reported previously in AML cells and is considered a target for therapy (20, 21). Here, CPT1A is linked to acute myeloid leukemia.